Speech-Language Pathology and Audiology: Industry Report

Summary

Speech-language pathology (SLP) and audiology serve a large and growing need. The World Health Organization (WHO) projects nearly 2.5 billion people with some degree of hearing loss ¹, and most people with disabling hearing loss live in low- and middle-income countries ¹. In the United States, the Bureau of Labor Statistics (BLS) reports about 193,400 SLP jobs and projects 17 percent employment growth ⁵, while ASHA survey respondents report widespread funded, unfilled positions ³. The FDA's over-the-counter (OTC) hearing aid category gives some adults a route to lower-cost devices ⁷⁸. The main risks are workforce shortage, affordability and low help-seeking ³⁷. The pack contains no verified market size, waiting-time, reimbursement or outcomes data. Based on these sources, our interpretation is that demand is likely to outpace supply over the near to medium term.

Key findings

1. 1

   Hearing loss burden is large and projected to rise

   WHO projects nearly 2.5 billion people with some degree of hearing loss, and nearly 80 percent of people with disabling hearing loss live in low- and middle-income countries. These are projections and burden estimates, not measures of service access.

   Confidence: High
2. 2

   US SLP employment is projected to grow

   BLS reports about 193,400 SLP jobs and projects 17 percent employment growth, with about 12,500 openings per year on average over the projection decade. The projection is a forecast.

   Confidence: High
3. 3

   Funded, unfilled SLP positions are common in US health care

   In the ASHA workforce survey, 56 percent of surveyed SLPs in health care reported more job openings than job seekers, and 57 percent of SLPs in pediatric hospitals reported funded, unfilled positions. Survey responses are self-reported.

   Confidence: Medium
4. 4

   Regulation has created an OTC hearing aid category for mild to moderate loss

   The FDA created an OTC category for adults 18 and older with perceived mild to moderate hearing loss. The FDA states the category aims to stimulate competition and offer less expensive devices. Only about one fifth of people who could benefit from a hearing aid seek intervention.

   Confidence: High
5. 5

   Traditional manufacturers still dominate the OTC hearing aid market

   A peer-reviewed analysis of an FDA registration database found the OTC hearing aid market still dominated by traditional hearing aid manufacturers. The analysis does not report market shares, so the degree of dominance is not quantified.

   Confidence: Medium

11. Industry definition and scope

This report covers speech-language pathology (SLP) and audiology, the professions that assess and treat communication, swallowing and hearing-related conditions. It uses two lenses: a global view of hearing loss burden and a United States view of SLP workforce, employment and hearing aid regulation. Canadian SLP registration is reported as one comparison point only ⁶.

The reporting period is the latest available data in the source pack. Projections are labelled as forecasts and are not treated as observed results. Where sources disagree, the report says so rather than choosing one figure.

Terminology differs across sources. WHO and the Global Burden of Disease (GBD) study count people with hearing loss ¹². BLS counts jobs ⁵. ASHA reports percentages of survey respondents ³⁴. ASHA membership counts ⁶ measure certified members, not practicing clinicians, and come from a third-party compilation.

Segments covered are hearing loss burden, hearing aid products including the OTC category, and SLP employment settings such as pediatric hospitals, skilled nursing facilities and home health ³⁴. The pack does not give a verified audiologist workforce count.

Scope is set by the sources available in the pack. Audiology workforce and service data were not verified, so audiology is covered mainly through hearing loss burden and hearing aid regulation.

22. Market size, structure and value chain

No verified global market size or revenue figure for SLP or audiology services was found in the pack, so this report does not estimate one. Demand is described instead through people affected, projected need and workforce size.

WHO estimates that unaddressed hearing loss carries an annual global cost of almost US$1 trillion ¹. This is an economic cost estimate, not market revenue, and it does not separate SLP from audiology spending. WHO also reports 95.1 million children aged 5 to 19 living with hearing loss ¹, which is an observed figure.

Projections differ slightly. WHO projects nearly 2.5 billion people with some degree of hearing loss ¹. The GBD study projects 2.45 billion, a 56.1 percent increase from its baseline, with stable age-standardized prevalence, and links the growth to population ageing ². The pack does not explain why the two figures differ, so the report treats them as a range.

In the United States, BLS reports a median pay of $97,870 per year for SLPs ⁵. ASHA reports 216,272 certified SLPs in the United States ⁶, a membership measure from a third-party blog. Canada had 12,111 regulated SLPs ⁶.

Value chain: the pack identifies employers as hospitals, skilled nursing facilities, home health and pediatric settings ³⁴. It does not give revenue shares, payer mix or cost per episode, so the flow of payment cannot be mapped. Other stakeholders in the pack are credentialing bodies, professional associations and regulators ⁶⁷⁸.

• People projected to have some degree of hearing loss 2.5billion people Forecast Global, Latest available data (projection) [1]
• Annual global cost of unaddressed hearing loss 1US$ trillion per year Estimate Global, Latest available data [1]

The S12 growth figure differs from the BLS figure of 17 percent ⁵. The report uses the BLS figure as the primary value because it is an official statistic.

33. Customers, demand and adoption

End-user groups in the pack are adults with hearing loss, children and adolescents with hearing loss, and patients in pediatric and adult care who need speech, language or swallowing services. A projected 15 percent SLP employment growth is attributed to pediatric and adult care needs ¹², a secondary summary of BLS data.

Access is uneven. Nearly 80 percent of people with disabling hearing loss live in low- and middle-income countries ¹. The pack does not give service coverage, waiting times or out-of-pocket costs in those countries, so the size of the access gap cannot be measured from these sources.

Adoption of hearing care is low. Only about one fifth of people who could benefit from a hearing aid seek intervention in the United States ⁷. The pack does not measure why. Cost, awareness and access are plausible explanations, but they are our interpretation, not findings of the sources.

Purchasing criteria are changing. The FDA says the OTC category aims to stimulate competition and offer devices less expensive than current options ⁸. The National Council on Aging states that eligible adults with mild to moderate loss can buy FDA-approved OTC hearing aids without a prescription and that the cost can be far lower than prescription models ¹¹. No verified price data were found, so the size of the saving is not quantified.

Quality expectations also shape demand. Among surveyed SLPs in skilled nursing facilities, 30 percent said they were pressured to provide group therapy when individual therapy was appropriate ³. This suggests that payment or staffing pressure can affect the type of care delivered, although the survey does not establish cause.

Demand and adoption findings rely on prevalence, survey and regulator sources. No waiting-time, outcome or utilization data were verified.

44. Competitive landscape and key players

The pack does not compare public, private and community providers. It does not report ownership mix, market shares, concentration or pricing by provider type. Employment settings are described instead: pediatric hospitals, where 57 percent of SLPs reported funded, unfilled positions ³; skilled nursing facilities, where group therapy pressure was reported ³; and home health, where SLPs were more likely than other health care SLPs to report openings exceeding job seekers ⁴. The home health finding has no figure in the pack.

In hearing aids, the regulatory change has created two business models. Traditional fitting involves professional selection and prescription ¹¹. The OTC model allows eligible adults with mild to moderate loss to buy without a prescription ⁷¹¹. A peer-reviewed analysis found the OTC market still dominated by traditional hearing aid manufacturers ¹⁰, which suggests incumbents are adapting to the new category. The analysis does not report shares.

Named companies are not covered by the pack, so this report does not compare individual firms. Company-level comparisons were limited in the source pack, and naming firms would require sources not verified here.

The main professional body in the pack is ASHA, which reports certified membership of 218,646 globally and 216,272 in the United States ⁶. That figure comes from a third-party blog compiling ASHA data, so it is used with caution.

Competitive pressure in OTC hearing aids is an intended policy effect: the FDA states the category aims to stimulate competition ⁸. Whether it has done so cannot be confirmed from the pack.

Comparable provider data and named company data were limited. Setting and business model comparisons are drawn from workforce surveys and regulatory summaries.

55. Technology, operations and workforce

Workforce strain is the clearest operating signal in the pack. Of SLPs surveyed in health care, 56 percent reported more job openings than job seekers, and 44 percent of clinical service providers had funded, unfilled SLP positions ³. The chart shows the survey indicators. A different ASHA resource reports that 20.4 percent of respondents said openings were fewer than job seekers in their setting and area ⁴. This figure points in the opposite direction, but it uses a different measure, so the two cannot be reconciled directly.

BLS projects about 12,500 SLP openings per year on average over the decade ⁵. These openings combine growth and replacement, but the pack does not separate them. Among employed survey respondents, 70 percent worked full time ³, which suggests that much of the workforce is in full-time roles.

Technology adoption is not well documented. The pack contains no verified telepractice or digital health uptake figure. One secondary blog cited a growth rate that conflicts with BLS, so it was excluded.

Established practice in the pack is in-person SLP and audiology care, along with prescribed hearing aid fitting ¹¹. The OTC hearing aid pathway is a newer, regulated option ⁷⁸. Its clinical and operational effects are not documented in the sources.

Operational practice matters for quality. The group therapy pressure reported in skilled nursing facilities ³ shows that staffing shortages may affect whether care is individualized. The pack does not measure outcomes, so this link is our interpretation.

• SLP jobs in the United States 193,400jobs Observed United States, Latest available data [5]

Workforce indicators come from an association survey and a BLS projection. The two sources use different definitions and should be compared with care.

66. Regulation, standards, risk and sustainability

The jurisdiction for hearing aid regulation in this report is the United States. Binding requirements: the FDA regulates hearing aids to provide reasonable assurance of safety and effectiveness ⁸. The final OTC rule was published in the Federal Register and took effect ⁹. The OTC category applies to adults 18 and older with perceived mild to moderate hearing loss ⁷. These are binding regulatory requirements, not proposals.

Voluntary guidance is different. The National Council on Aging provides consumer buying guidance on OTC hearing aids ¹¹. This guidance is not a regulatory requirement. This report is not legal, medical or purchasing advice, and individuals should consult a licensed professional about their own hearing or communication needs.

The pack does not verify SLP or audiology licensure rules, scope of practice, privacy requirements, ethics codes or environmental factors. These gaps mean the report cannot assess them.

Social and equity factors include the concentration of disabling hearing loss in low- and middle-income countries ¹ and the low share of people with benefit-eligible hearing loss who seek care ⁷. Operational risks include workforce shortage ³ and the cost burden of unaddressed hearing loss ¹.

Regulatory statements are limited to the US hearing aid framework in the pack. Canadian and other national SLP regulation is not covered.

77. Challenges, opportunities and case examples

Major constraints are workforce shortage, access gaps and low help-seeking. Funded, unfilled positions are reported in pediatric hospitals at 57 percent ³. Only about one fifth of people who could benefit from a hearing aid seek care ⁷. Affordability is also a constraint, although the pack gives no verified price data ¹¹.

Opportunities follow from demand. The projected growth in hearing loss prevalence and SLP employment ¹²⁵ suggests continued need. The OTC category may widen access for adults with mild to moderate loss ⁷⁸, subject to the eligibility limits.

Case example 1: the FDA OTC hearing aid category. The regulator created a new route for eligible adults, with the stated aim of more competition and lower-cost devices ⁷⁸⁹. Its effect on prices and uptake is not measured in the pack.

Case example 2: traditional manufacturers in the OTC market. A peer-reviewed analysis of FDA registration data found the OTC market still dominated by traditional manufacturers ¹⁰. This suggests incumbents have stayed central to the new category, although market shares are not reported.

Case example 3: pediatric hospitals. A 57 percent share of SLPs reporting funded, unfilled positions ³ shows how workforce strain appears in a specific setting. Company-level examples were limited in the pack, so the examples here are regulatory and setting-level.

Case examples are drawn only from the pack. Company names and outcome results were not verified.

88. Outlook and strategic implications

Near term: the sources point to continued workforce strain. Survey results show high rates of unfilled positions ³, and BLS projects both growth and openings ⁵. We interpret this as a likely persistence of shortages, although the pack does not provide a supply forecast.

Medium term: demand is likely to grow. WHO and GBD projections of rising hearing loss prevalence ¹² and the BLS employment projection ⁵ point the same way. Population ageing is the driver named in the GBD study ². The OTC pathway may shift some hearing care toward self-selected devices for eligible adults ⁷⁸¹¹.

Uncertainties: the effect of OTC devices on outcomes, the size of cost savings, telepractice adoption and reimbursement are not verified. Scenarios: a base case of steady demand and constrained supply; a faster-demand case if help-seeking rises; and a constrained-access case if workforce gaps persist in lower-resourced settings.

Practical implications: employers may need to address recruitment and retention in settings with high vacancy reports ³⁴. Providers should monitor the balance between group and individual therapy ³. Regulators should track OTC uptake and outcomes, which the pack does not yet document. Consumers with mild to moderate loss can review OTC eligibility ⁷¹¹. Payers need payment data that the pack does not supply.

Outlook is based on projections and survey data. The pack lacks outcome, cost and reimbursement data needed for a stronger assessment.

99. Conclusion

Demand for SLP and audiology care is large and projected to grow, and US workforce strain is widely reported. The OTC hearing aid category is a significant regulatory change, but its effects on access and cost are not yet measured in the sources. The most defensible takeaways are the scale of need, the workforce gap and the importance of verified outcome and payment data.

How this was built

Sources

1. 1

   Deafness and hearing loss (fact sheet)

   World Health Organization Official statistics

   who.int
2. 2

   Hearing loss prevalence and years lived with disability: findings from the Global Burden of Disease Study

   GBD Hearing Loss Collaborators (published in PubMed Central) Peer-reviewed

   ncbi.nlm.nih.gov
3. 3

   ASHA SLP Health Care Survey: Workforce

   American Speech-Language-Hearing Association Industry association

4. 4

   Supply and Demand Resource List for Speech-Language Pathologists

   American Speech-Language-Hearing Association Industry association

   asha.org
5. 5

   Speech-Language Pathologists, Occupational Outlook Handbook

   U.S. Bureau of Labor Statistics Official statistics

   bls.gov
6. 6

   SLP Statistics: Caseload, Salary, Shortage (US, Canada)

   GA-Loo (third-party blog compiling ASHA and BLS data) News report

   ga-loo.com
7. 7

   OTC Hearing Aids: What You Should Know

   U.S. Food and Drug Administration Regulator

   fda.gov
8. 8

   Hearing Aids and Personal Sound Amplification Products: What to Know

   U.S. Food and Drug Administration Regulator

   fda.gov
9. 9

   Over-the-Counter Hearing Aids Final Rule (Hearing Industries Association summary)

   Hearing Industries Association Industry association

   betterhearing.org
10. 10

    Frontiers article: Over-the-counter hearing aids: implementations and opportunities

    Frontiers in Audiology and Otology (peer-reviewed) Peer-reviewed

11. 11

    Hearing Aid Cost and Access (NCOA guide on OTC hearing aids)

    National Council on Aging Industry association

    ncoa.org
12. 12

    Speech-Language Pathology Career Outlook (BLS-based summary)

    University of Saint Augustine (USAHS) News report

    usa.edu